Toralgen
Dod Michael's work experience includes positions at Joslin Diabetes Center as a Post-doctoral Fellow, Eli Lilly and Company in various roles including Sr Director of Insulin Discovery, Thermalin Inc. as President and Chief Scientific Officer, Stealth Mode Biotech as Chief Scientific Officer, and Toralgen as Vice President of Metabolic Diseases. Dod also held roles as an Adjunct Professor at Indiana University School of Medicine and Adjunct Faculty at University of Indianapolis and Ivy Tech Community College.
Dod Michael earned their Bachelor of Science in Biology/Biochemistry from The University of Alabama in 1991. Dod then went on to complete their PhD in Cell and Molecular Biology at UT Southwestern Medical Center, graduating in 1997.
This person is not in any offices
Toralgen
Toralgen is a is a preclinical stage biopharmaceutical company that specializes in the development and commercialization of human therapeutics. They eliminates the challenges of oral delivery in one simple-to-fabricate nanopill. These nanopills also localize the delivery of drug agents and improve the efficacy and safety of therapies.